Related Experiment Video
Updated: May 19, 2026
04:22
Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
Published on: March 30, 2017
Rational design of a dry powder inhaler: device design and optimisation
Christian Friebel1, Hartwig Steckel, Bernd W Müller
1Welding GmbH & Co. KG, Hamburg, Germany.
The Journal of Pharmacy and Pharmacology
|August 14, 2012
Summary
This study developed a modular inhaler for asthma and COPD treatment using statistical methods. Optimized dimensions maximize fine particle delivery and minimize throat deposition for an effective dry powder inhalation system.
Area of Science:
- Pharmaceutical Technology
- Biomedical Engineering
- Drug Delivery Systems
Background:
- Development of dry powder inhalers (DPIs) for respiratory diseases like asthma and COPD requires precise device engineering.
- Optimizing inhaler design is crucial for efficient drug delivery and patient outcomes.
Purpose of the Study:
- To systematically and cost-effectively develop an inhalation device for asthma and COPD treatment.
- To investigate the influence of inner dimensions on airflow resistance and in-vitro deposition characteristics.
Main Methods:
- A modular inhaler concept was developed based on theoretical design and prototyping.
- Statistical design of experiments (DoE) and cascade impaction analysis were employed.
- In-vitro deposition studies were conducted to evaluate aerodynamic performance.
Main Results:
- A statistical model accurately predicted device resistance based on inner dimensions.
- Optimized inner dimensions were defined to maximize fine particle fraction (FPF).
- Oropharyngeal deposition was minimized within the desired airflow resistance range.
Conclusions:
- The modular inhaler concept and DoE are effective tools for efficient product development.
- This approach enabled the cost-effective design of a technically feasible and competitive DPI.
- The study provides a framework for optimizing DPI performance for respiratory conditions.
Related Concept Videos
01:23Inhaled Medications
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
01:22Biopharmaceutical Factors Influencing Drug Product Design: Overview
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...